2021 International Conference on E-Health and Bioengineering (EHB) 2021
DOI: 10.1109/ehb52898.2021.9657725
|View full text |Cite
|
Sign up to set email alerts
|

Convolutional Neural Network Detecting Synthetic Cannabinoids

Abstract: We are presenting a convolutional neural network (CNN) application recognizing the class identity of synthetic cannabinoids based on their Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) spectra. The results indicate that this CNN system can be efficiently used to distinguish JWH synthetic cannabinoids from other substances of forensic interest, but also from other types of synthetic cannabinoids. One of the main advantages of the system is that it can also operate on mobile ATR-FTIR spectrom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…Hence, the input database was a matrix consisting of 150 samples × 150 variables. The shape, feature and target types of the data set, including the list of the computed and tested input molecular descriptors was presented in a previously published article [7].…”
Section: Methodsmentioning
confidence: 99%
“…Hence, the input database was a matrix consisting of 150 samples × 150 variables. The shape, feature and target types of the data set, including the list of the computed and tested input molecular descriptors was presented in a previously published article [7].…”
Section: Methodsmentioning
confidence: 99%
“…The group of positives contains 50 JWH synthetic cannabinoids, while the group of negatives includes 100 compounds (50 non-JWH cannabinoids and 50 others drugs). The list of these compounds was presented in a previous paper [2].…”
Section: Amentioning
confidence: 99%
“…Our research is part of ongoing efforts addressing the growing challenges of synthetic drug proliferation. In a prior study, we obtained promising results with a DCNN model based on the adapted Inception-V3 architecture [14]. In this work, we have presented the performances of a custom-designed DCNN, which was developed from scratch and combined with a specially designed pre-trained Convolutional Autoencoder.…”
Section: Introductionmentioning
confidence: 99%